Chemomab Therapeutics Q4 EPS $(0.24) Beats $(0.40) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings BeatsNews
Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.40) by 40 percent. This is a 62.5 percent increase over losses of $(0.64) per share from
Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.40) by 40 percent. This is a 62.5 percent increase over losses of $(0.64) per share from the same period last year.